about
DNA/MVA Vaccination of HIV-1 Infected Participants with Viral Suppression on Antiretroviral Therapy, followed by Treatment Interruption: Elicitation of Immune Responses without Control of Re-Emergent VirusHigh Doses of GM-CSF Inhibit Antibody Responses in Rectal Secretions and Diminish Modified Vaccinia Ankara/Simian Immunodeficiency Virus Vaccine Protection in TRIM5α-Restrictive Macaques.HIV transmitted/founder vaccines elicit autologous tier 2 neutralizing antibodies for the CD4 binding siteWorking towards an HIV/AIDS vaccine.Ebola virus – prospects for a novel virus-like-particle-expressing modified vaccinia Ankara-based vaccineHIV/AIDS Vaccines: 2018Protective immunity from a germinal center sanctuary
P50
Q28554534-9EF81969-FF2F-4EBB-B9FC-1F8B1EB38B53Q40523370-EBFBD836-0FAC-439B-A508-43C343C1A568Q41919287-E433668F-DAA5-4E94-90EB-CD612D427258Q43773706-9E6DD6AF-8399-44A5-9F87-D0F99E6B3839Q56777301-CB94C7D5-7BD0-4577-B717-5E19C914A42EQ59354714-A0867DE2-74FE-4406-9704-870A68103D19Q85389313-27A342A9-C59C-4360-9227-CE8F35931F84
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Harriet L Robinson
@ast
Harriet L Robinson
@en
Harriet L Robinson
@es
Harriet L Robinson
@nl
type
label
Harriet L Robinson
@ast
Harriet L Robinson
@en
Harriet L Robinson
@es
Harriet L Robinson
@nl
prefLabel
Harriet L Robinson
@ast
Harriet L Robinson
@en
Harriet L Robinson
@es
Harriet L Robinson
@nl
P106
P108
P31
P496
0000-0001-6380-3458